Head and neck tumor organoid biobank for modelling individual responses to radiation therapy according to the TP53/HPV status.
Saved in:
| Title: | Head and neck tumor organoid biobank for modelling individual responses to radiation therapy according to the TP53/HPV status. |
|---|---|
| Authors: | Issing C; Department of Otorhinolaryngology, Goethe University Frankfurt, University Hospital, Frankfurt/Main, Germany. christian.issing@unimedizin-ffm.de.; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt/Main, Germany. christian.issing@unimedizin-ffm.de.; Frankfurt Cancer Institute, Goethe University Frankfurt, Frankfurt/Main, Germany. christian.issing@unimedizin-ffm.de.; University Cancer Center (UCT) Frankfurt, Goethe University Frankfurt, University Hospital, Frankfurt/Main, Germany. christian.issing@unimedizin-ffm.de.; Mildred-Scheel Early Career Center Frankfurt, Frankfurt/Main, Germany. christian.issing@unimedizin-ffm.de.; German Cancer Consortium (DKTK), Frankfurt/Mainz partner site and German Cancer Research Center (DKFZ), Heidelberg, Germany. christian.issing@unimedizin-ffm.de., Menche C; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt/Main, Germany.; German Cancer Consortium (DKTK), Frankfurt/Mainz partner site and German Cancer Research Center (DKFZ), Heidelberg, Germany., Richter MR; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt/Main, Germany., Mosa MH; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt/Main, Germany.; Frankfurt Cancer Institute, Goethe University Frankfurt, Frankfurt/Main, Germany., von der Grün J; Mildred-Scheel Early Career Center Frankfurt, Frankfurt/Main, Germany.; Department of Radio-oncology, University Hospital Zürich, Zürich, Switzerland., Fleischmann M; Frankfurt Cancer Institute, Goethe University Frankfurt, Frankfurt/Main, Germany.; German Cancer Consortium (DKTK), Frankfurt/Mainz partner site and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Radiotherapy and Oncology, Goethe University Frankfurt, University Hospital, Frankfurt/Main, Germany., Thoenissen P; Clinic of Oral, Cranio-Maxillofacial and Plastic Facial Surgery, Goethe University Frankfurt, University Hospital, Frankfurt/Main, Germany., Winkelmann R; Dr. Senckenberg Institute for Pathology and Human Genetics, Goethe University Frankfurt, University Hospital, Frankfurt/Main, Germany., Darvishi T; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt/Main, Germany., Loth AG; Department of Otorhinolaryngology, Goethe University Frankfurt, University Hospital, Frankfurt/Main, Germany., Ghanaati S; Clinic of Oral, Cranio-Maxillofacial and Plastic Facial Surgery, Goethe University Frankfurt, University Hospital, Frankfurt/Main, Germany., Rödel F; Frankfurt Cancer Institute, Goethe University Frankfurt, Frankfurt/Main, Germany.; German Cancer Consortium (DKTK), Frankfurt/Mainz partner site and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Radiotherapy and Oncology, Goethe University Frankfurt, University Hospital, Frankfurt/Main, Germany., Wild PJ; Frankfurt Cancer Institute, Goethe University Frankfurt, Frankfurt/Main, Germany.; University Cancer Center (UCT) Frankfurt, Goethe University Frankfurt, University Hospital, Frankfurt/Main, Germany.; Dr. Senckenberg Institute for Pathology and Human Genetics, Goethe University Frankfurt, University Hospital, Frankfurt/Main, Germany., Brandts CH; Frankfurt Cancer Institute, Goethe University Frankfurt, Frankfurt/Main, Germany.; University Cancer Center (UCT) Frankfurt, Goethe University Frankfurt, University Hospital, Frankfurt/Main, Germany.; German Cancer Consortium (DKTK), Frankfurt/Mainz partner site and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, University Hospital, Frankfurt/Main, Germany., Stöver T; Department of Otorhinolaryngology, Goethe University Frankfurt, University Hospital, Frankfurt/Main, Germany., Farin HF; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt/Main, Germany. h.farin@georg-speyer-haus.de.; Frankfurt Cancer Institute, Goethe University Frankfurt, Frankfurt/Main, Germany. h.farin@georg-speyer-haus.de.; German Cancer Consortium (DKTK), Frankfurt/Mainz partner site and German Cancer Research Center (DKFZ), Heidelberg, Germany. h.farin@georg-speyer-haus.de. |
| Source: | Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2025 Mar 05; Vol. 44 (1), pp. 85. Date of Electronic Publication: 2025 Mar 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
